A retrospective study evaluating efficacy and safety of compassionate use of tocilizumab in 13 patients with severe-to-critically ill COVID-19: analysis of well-responding cases and rapidly-worsening cases after tocilizumab administration

Shoji Hashimoto; Heita Kitajima; Tsuyoshi Arai; Yoshitaka Tamura; Takayuki Nagai; Hiroshi Morishita; Hiroto Matsuoka; Yuki Han; Seijiro Minamoto; Tomonori Hirashima; Tomoki Yamada; Yozo Kashiwa; Makoto Kameda; Seiji Yamaguchi; Kazuko Uno; Emi Nakayama; Tatsuo Shioda; Kazuyuki Yoshizaki; Sujin Kang; Tadamistu Kishimoto; Toshio Tanaka.
Preprint en Inglés | PREPRINT-MEDRXIV | ID: ppmedrxiv-20134288

Documentos relacionados

  1. Ocular Involvement in COVID-19: Conjunctivitis and More.
  2. [Vitamin D and COVID-19: a communication far from reality].
  3. [Mental disorders associated with acute COVID-19: clinical picture, therapy approaches].
  4. [Alopecia and COVID-19: possible etiopathogenetic variants and therapeutic approach].
  5. [COVID-19: treatment strategies of German-speaking pediatric rheumatologists : Results of an online survey].
  6. [Social Inequalities and COVID-19: Social-Epidemiological Perspectives on the Pandemic].
  7. [Acute kidney injury and COVID-19: lung-kidney crosstalk during severe inflammation].
  8. [Coagulopathy in COVID-19: pathophysiology].
  9. [Drug treatment of coronavirus disease COVID-19: evidence exists?]
  10. [COVID-19: epidemiology and mutations : An update].